Have a personal or library account? Click to login
Liraglutide Attenuates Endothelial Dysfunction by Inhibiting Hyperglycemia-Induced Endothelial Cell Senescence Through the LARP7/SIRT1 Pathway Cover

Liraglutide Attenuates Endothelial Dysfunction by Inhibiting Hyperglycemia-Induced Endothelial Cell Senescence Through the LARP7/SIRT1 Pathway

Archivum Immunologiae et Therapiae Experimentalis
Volume 74 (2026): Issue 1 (January 2026)
By: Weili Zhong,  Ying Yang and  Yanru Wang  
Open Access
|Dec 2025

Authors

Weili Zhong

zhongweili_smh@126.com

Endocrinology Department Three Wards, Harbin Medical University Affiliated Fourth Hospital, Harbin, China

Ying Yang

Endocrinology Department Three Wards, Harbin Medical University Affiliated Fourth Hospital, Harbin, China

Yanru Wang

Endocrinology Department Three Wards, Harbin Medical University Affiliated Fourth Hospital, Harbin, China
DOI: https://doi.org/10.2478/aite-2026-0006 | Journal eISSN: 1661-4917
Journal RSS Feed
Language: English
Submitted on: Mar 17, 2025
Accepted on: Sep 23, 2025
Published on: Dec 4, 2025
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Liraglutide,
Endothelial cell senescence,
Oxidative stress,
LARP7,
SIRT1
Related subjects:
Medicine,
Basic medical science,
Biochemistry,
Immunology,
Clinical medicine,
Clinical medicine, other,
Clinical chemistry

© 2025 Weili Zhong, Ying Yang, Yanru Wang, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 74 (2026): Issue 1 (January 2026)